← Back to Clinical Trials
Recruiting NCT07524751

NCT07524751 Culturally Adapted Pain Management for Indigenous Peoples

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07524751
Status Recruiting
Phase
Sponsor University of California, San Diego
Condition Chronic Pain
Study Type INTERVENTIONAL
Enrollment 30 participants
Start Date 2026-06-15
Primary Completion 2028-06-30

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age N/A
Study Type INTERVENTIONAL
Interventions
Braided Skills for Managing Pain

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 30 participants in total. It began in 2026-06-15 with a primary completion date of 2028-06-30.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The proposed study involves a randomized feasibility pilot trial of a culturally adapted psychological intervention for chronic pain for American Indian/Alaska Native (AI/AN) individuals receiving care for pain at the Portland Area Indian Health Service - Yakama Service Unit. The study will provide information on whether or not it is feasible to conduct a future fully-powered randomized controlled trial.

Eligibility Criteria

Inclusion Criteria: * at least 18 years of age * identify as AI/AN (or by another preferred name, such Native American, Native, and/or Indigenous) * have at least one diagnosis consistent with chronic pain and/or meet criteria for chronic pain diagnosis at enrollment (i.e., experience pain for \> 50% in the past 3 months that interferes with daily functioning) * possess the ability to speak and understand English * have access to a mode of communication for contact, such as a telephone, for study purposes Exclusion Criteria: * significant cognitive impairment * current uncontrolled serious psychological issues (e.g., schizophrenia, bipolar disorder) * active medical treatment for malignant conditions (e.g., cancer) * active suicidality with intent * active alcohol and/or substance abuse

Contact & Investigator

Central Contact

Andrea K Newman, PhD

✉ a7newman@health.ucsd.edu

📞 253-271-4289

Frequently Asked Questions

Who can join the NCT07524751 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, studying Chronic Pain. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07524751 currently recruiting?

Yes, NCT07524751 is actively recruiting participants. Contact the research team at a7newman@health.ucsd.edu for enrollment information.

Where is the NCT07524751 trial being conducted?

This trial is being conducted at Yakima, United States.

Who is sponsoring the NCT07524751 clinical trial?

NCT07524751 is sponsored by University of California, San Diego. The trial plans to enroll 30 participants.

Related Trials

Related Intelligence Guides

In-depth guides covering this condition's trials, eligibility, and what to expect.

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology